|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-8-22
|
|
pubmed:abstractText |
To define the best strategy to reduce Compound A production in Sevoflurane low-flow anaesthesia by experiments in vitro and in vivo of different absorbers and different anaesthesia machines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0001-5172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1017-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12190805-Absorption,
pubmed-meshheading:12190805-Anesthesia, Closed-Circuit,
pubmed-meshheading:12190805-Anesthetics, Inhalation,
pubmed-meshheading:12190805-Carbon Dioxide,
pubmed-meshheading:12190805-Ethers,
pubmed-meshheading:12190805-Humans,
pubmed-meshheading:12190805-Hydrocarbons, Fluorinated,
pubmed-meshheading:12190805-Methyl Ethers
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Sevoflurane low-flow anaesthesia: best strategy to reduce Compound A concentration.
|
|
pubmed:affiliation |
Department of Medical and Surgical Critical Care, University of Florence, Italy. aledanibatibeba@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
In Vitro
|
